Aciherpin

Quick links to important sections

Aciherpin

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aciherpin

What is Aciherpin?

Aciherpin is a pharmaceutical medication developed specifically for the treatment of viral infections caused by the herpes simplex virus (HSV). It belongs to a class of drugs known as antivirals.

Composition and Mechanism

The active therapeutic agent in Aciherpin is acyclovir. This compound is a purine nucleoside analogue that serves as a selective inhibitor of viral replication. When the medication enters a cell infected by the virus, it undergoes a chemical conversion that allows it to integrate into the viral DNA chain. Once incorporated, it acts as a chain terminator, effectively stopping the virus from copying its genetic material and preventing the spread of the infection to healthy cells.

Therapeutic Use

Aciherpin is primarily utilized to manage various conditions associated with the herpes simplex virus, including:

  • Labial Herpes: Commonly referred to as cold sores, affecting the lips and mouth area.
  • Genital Herpes: Infections affecting the reproductive tract and surrounding skin.
  • Primary and Recurrent Infections: It is used both for the initial outbreak of the virus and for subsequent episodes.

Clinical Role

It is important to note that while Aciherpin is effective at suppressing the replication of the virus and accelerating the healing process of visible sores, it does not eliminate the virus from the body. The herpes simplex virus typically remains dormant in nerve ganglia; Aciherpin works to manage active symptoms and reduce the duration of viral shedding during an outbreak.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Aciherpin?

Possible side effects and safety information

The safety profile of Aciherpin (Aciclovir) is formally established through regulatory documents, which classify documented adverse reactions based on their frequency of occurrence and the physiological system affected. This classification system, used by authorities such as the EMA and FDA, distinguishes between common, less common, and rare events.

Officially listed Common systemic adverse reactions (affecting between 1 in 10 and 1 in 100 people) often involve the Gastrointestinal system, including nausea, vomiting, diarrhoea, and abdominal pain. Nervous System effects classified as Common include headache and dizziness. For topical formulations, transient local reactions like stinging or burning may occur.

Adverse reactions classified as Rare or Very Rare are of higher clinical concern and are formally documented. Very Rare effects (less than 1 in 10,000 people) include disorders of the Blood and Lymphatic System (e.g., leukopenia, anaemia) and severe Renal and Urinary Disorders, such as Acute Renal Failure. Serious neurological events, including encephalopathy, seizures, and coma, are also documented as Very Rare and are generally described as reversible upon stopping the medicine.

Regulatory safety information highlights specific considerations for certain patient groups. Older adults and individuals with renal impairment are noted to have an increased susceptibility to neurological side effects due to the drug’s elimination characteristics. Adequate hydration is an essential safety note defined in regulatory documents to mitigate the risk of renal complications. The overall safety structure ensures that the spectrum of potential risks is clearly delineated based on standardized governmental reporting.

Overdose and Emergency Response

The official regulatory profile for Aciherpin (Aciclovir) overdose focuses on documenting two primary areas of severe toxicity: central nervous system (CNS) effects and acute renal impairment. The manifestations listed are based on reports associated with high doses or impaired drug clearance.

Overdose Manifestations and Risks Official Emergency Actions
CNS Effects: Documented symptoms include agitation, confusion, hallucinations, lethargy, somnolence, and, in severe cases, progression to seizures and coma. Seek Urgent Help: Immediate medical attention is required if an individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.
Renal Toxicity: Overdosage, particularly with high doses or impaired renal function, may lead to the precipitation of drug crystals (crystalluria) and result in acute renal failure (AKI), which has, in some cases, led to death. Supportive Management: Treatment is based on symptomatic and supportive care. Hemodialysis is documented as a method to significantly decrease plasma concentrations of the drug in cases of severe toxicity.
At-Risk Populations: Patients with pre-existing renal impairment or the elderly are noted in labeling to be at increased risk of neurological side effects and systemic toxicity due to slower drug clearance. Required Monitoring: Close observation and continuous monitoring of renal function markers and fluid balance are required during treatment for suspected overdose.

The regulatory guidance emphasizes that when severe, life-threatening symptoms such as loss of consciousness or seizures occur, individuals must immediately contact emergency services. Management is defined by supportive measures and the potential use of hemodialysis to expedite drug removal, as documented in official prescribing information.

Therapeutic Uses of Aciherpin

What Aciherpin Treats: Main Uses and Benefits

Aciherpin (Aciclovir) is a relevant therapeutic agent used to manage conditions and symptoms stemming from specific viral infections, primarily those caused by the Herpes Simplex Virus (HSV) and the Varicella-Zoster Virus (VZV). Its use is generally applied across domains where additional symptomatic support is needed to ease the overall symptom load. This medication is commonly used to treat conditions involving acute or recurrent viral manifestations.

The medication is generally considered relevant for easing symptoms associated with genital herpes, cold sores (Herpes Labialis), shingles (Herpes Zoster), and sometimes chickenpox, along with providing support in severe, systemic viral conditions.


Therapeutic Focus and Patient Benefits

Aciherpin is commonly used across conditions presenting with acute episodes that involve visible formation of blisters and sores, as well as the accompanying neurosensory discomfort like pain, burning, itching, and tingling. The primary goal is to assist with the healing of these lesions and help lessen the intensity of uncomfortable symptoms, offering symptomatic relief that helps patients cope more steadily with difficult episodes.

It is also applicable within clinical settings that involve acute or disruptive symptom patterns, such as the long-term management of frequently recurring genital herpes. For patients with high-risk infections, it provides supportive relief to ease the impact of severe manifestations, particularly in immunocompromised individuals.

“The medication helps address symptom clusters that may become intense or disruptive, supporting the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Neurosensory Discomfort
Aciherpin may assist with managing the sensations of pain and tingling that often signal or accompany an active viral outbreak, contributing to improved comfort.

Regulatory References

  1. NIH MedlinePlus overview of Acyclovir

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Aciherpin (Aciclovir) — official regulatory information

Populations for whom use is contraindicated:

  • Patients with known hypersensitivity (allergic reaction) to the active substance aciclovir, its precursor valaciclovir, or any component of the formulation.

Age and Condition-specific Eligibility Rules

Classification Restriction or Conditional Use
Renal Impairment Requires use to be restricted via dose adjustment due to the drug's dependence on kidney clearance.
Older Adults Requires special consideration and close monitoring due to likely reduced kidney function and increased risk of neurological effects.
Pediatric Patients Use is established for appropriate viral indications, though safety and efficacy may not be established for all forms/uses in very young children.
Pregnancy and Lactation Use in pregnancy is conditional and generally reserved for when potential benefits justify potential risks. Caution is advised when breastfeeding, as aciclovir is detected in breast milk.

Connection to the overall eligibility profile Official regulatory documents define who can and cannot use this medicine by establishing a mandatory contraindication for individuals with known hypersensitivity to its components. Furthermore, eligibility is restricted for populations with reduced kidney function, such as the elderly and those with renal impairment. Use during pregnancy and lactation is also conditional, being reserved by regulators for specific clinical circumstances.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions with Aciherpin (Acyclovir) that are officially documented in authoritative governmental regulatory sources.


Pharmacokinetic Interactions

Aciherpin is primarily eliminated from the body unchanged through the kidneys via active renal tubular secretion. Clinically significant drug interactions occur when co-administered medicines compete for this specific clearance mechanism.

Interacting Agent Resulting Effect on Aciherpin
Probenecid Significantly increases Aciherpin plasma concentration (AUC) and half-life by reducing renal clearance.
Cimetidine Increases Aciherpin plasma concentration (AUC) through competition for tubular secretion.
Mycophenolate Mofetil (MMF) Results in increased AUC for both Aciherpin and the inactive MMF metabolite, due to competition for renal tubular secretion.

Pharmacodynamic and Safety Interactions

Interacting Category Practical Implication
Nephrotoxic Agents Co-administration with other drugs known to cause kidney injury (nephrotoxicity) increases the overall risk of renal dysfunction or impairment. Caution is advised.

General Interaction Profile

Aciherpin's metabolism by liver enzymes is minimal, resulting in a low potential for interactions mediated by the cytochrome P450 (CYP) system. Oral absorption of Aciherpin is not significantly affected by food and no specific interactions with alcohol or commonly used herbal products are officially documented.

Mechanism of Action

Selective Activation by Viral Enzymes

Aciherpin (Aciclovir) is an inactive prodrug that requires transformation to become functionally active. This process is initiated within infected cells by the Viral Thymidine Kinase (vTK), an enzyme predominantly associated with the pathogen. The vTK performs the crucial first step of phosphorylation, converting the drug into a monophosphate. Subsequent phosphorylation by host cellular kinases results in the formation of Aciclovir Triphosphate (ACV-TP). This mechanism ensures the concentration of the active drug form at the precise site of viral activity, which dictates the location of the molecule's action.


Irreversible Suppression of Viral DNA Synthesis

The active ACV-TP acts as a competitive inhibitor of the essential Viral DNA Polymerase enzyme. Structurally mimicking a natural building block, the molecule is incorporated into the growing viral DNA strand. However, due to the absence of the necessary chemical site for linkage, the drug immediately halts the synthesis process through DNA chain termination. This key mechanistic cascade results in the irreversible cessation of the viral genome duplication cycle, which functionally prevents the proliferation of viral particles.

Dosage and Administration Information

How to Use Aciherpin: Official Administration Guidelines

Aciherpin (Aciclovir) is prescribed via various routes, with the specific choice depending on the infection's severity and location. The proper administration is defined by a set of dose, frequency, and duration requirements.


Administration Routes and Dosing Patterns

The medicine is available for oral (tablets/suspension), intravenous (IV) infusion, topical (cream/ointment), and ophthalmic use.

Administration Type Standard Adult Regimens Course Duration Pattern
Oral Acute 200 mg to 800 mg, typically five times daily (e.g., every 4 hours while awake). 5 to 10 days, depending on the infection.
Oral Suppression 400 mg twice daily or 200 mg three to five times daily. Up to 12 months, with re-evaluation required periodically.
Intravenous (IV) 5 mg/kg or 10 mg/kg body weight, every 8 hours. 7 to 21 days, depending on the severity.
Topical Cream applied five times daily. Usually 5 to 10 days.

Procedural and Population Requirements

Special Conditions for Use: Oral Aciherpin may be taken with or without food. Regardless of the route, patients must maintain adequate hydration to support proper kidney function. IV administration is strictly procedural; the reconstituted drug must be infused slowly over a one-hour period to prevent administration-related issues.

Dose Adjustment: Official instructions mandate that the dosage and frequency must be reduced in patients with impaired renal function (kidney function). Dosage reduction is also often considered for older adults due to age-related changes in renal clearance. If a dose is missed, the general protocol is to take it as soon as remembered, unless it is close to the next scheduled dose, in which case the missed dose should be skipped. This framework ensures the medicine is used according to the precise parameters established for its administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aciherpin

Aciherpin (Aciclovir) has been the subject of research for many years, and the evidence base consists of controlled clinical trials, including randomized controlled trials (RCTs), systematic reviews, and meta-analyses. These studies are designed to explore how the medicine was observed in specific patient groups and what patterns of outcomes related to physical discomfort data show patterns related to the various viral infections it was evaluated in.


Evidence for Use in Recurrent Viral Outbreaks (Herpes Simplex)

For cold sores, RCTs were evaluated in immunocompetent adults. These studies explored the time required for lesions to heal and symptoms like pain. Findings describe patterns observed in the studies where measurements related to lesion healing time were compared between groups receiving Aciherpin and placebo. Research describes how the use of Aciherpin was observed to correlate with patterns related to active symptoms and viral shedding, but does not determine whether an individual will respond similarly or affect the latent virus. What remains uncertain is a deeper understanding of the long-term effects, and the data for certain groups remain insufficient.


Evidence for Severe, Systemic Viral Conditions

The use of Aciherpin for severe, systemic conditions, such as those affecting the brain (HSV Encephalitis), was studied for outcomes related to physiological strain or stress. Due to the high-risk nature of these conditions associated with acute or disruptive episodes, research relies on observational cohort studies, as placebo-controlled trials are not ethically feasible. The findings describe patterns observed in the studies that compared outcomes when Aciherpin was observed in the treatment regimen versus historical data. What remains uncertain is that the research data are still emerging from large, prospective RCTs in adults, and the subgroup findings are uncertain for many less common presentations. The findings reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Aciherpin (FAQ)

Q: What is Aciherpin used for, exactly?

A: According to regulatory documents, Aciherpin is indicated for treating infections caused by the herpes simplex virus (HSV), which includes outbreaks like genital herpes and cold sores, and the varicella-zoster virus (VZV), which is the virus responsible for shingles and chickenpox. Its purpose is to help the body control the infection by slowing the virus's ability to replicate.

Q: Why do official documents state that Aciherpin is only for certain infections?

A: Aciherpin is a highly selective antiviral drug. Its mechanism of action relies on an enzyme found predominantly in the targeted viral cells (HSV and VZV). This selective process ensures the drug primarily disrupts the DNA replication of only those specific viruses, which dictates its authorized use.

Q: What is the main difference between Aciherpin and generic alternatives?

A: Aciherpin is a brand name for the drug whose active ingredient is Acyclovir. Generic alternatives contain the identical active ingredient, and regulatory bodies require that generic products meet the same high standards for quality, strength, and effectiveness as the brand-name product.

Q: Is there a generic version of Aciherpin available?

A: Yes, the active ingredient in Aciherpin, Acyclovir, is widely available as a generic drug in many of the same forms (tablets, creams, IV solutions) and strengths, as confirmed by official drug listings.

Q: Are there different strengths of Aciherpin available?

A: Yes. Official drug monographs confirm that Aciherpin (Acyclovir) is manufactured in several dosage strengths. For oral tablets, common strengths listed include 200, mg, 400, mg, and 800, mg. These strengths allow for flexibility in the prescribed regimen.

Q: Is Aciherpin the same as other medicines ending in '-vir'?

A: Aciherpin (Acyclovir) belongs to a broad pharmacological class of antiviral drugs, many of which use the suffix -vir (like Valaciclovir or Famciclovir). While this suffix signals an antiviral function, each drug with this name ending is a distinct chemical entity with its own specific way of being absorbed and processed by the body.

Q: What is the purpose of the inactive ingredients in Aciherpin tablets?

A: The active ingredient Acyclovir is combined with pharmaceutical excipients (inactive ingredients). Official manufacturing standards require these ingredients for essential purposes such as binding the tablet together, helping the medicine dissolve correctly for absorption, and maintaining product stability.

Q: Is Aciherpin a prescription-only drug?

A: Official documentation generally indicates that Aciherpin is typically indicated for prescription use. This classification helps ensure proper diagnosis and monitoring, given the drug's use against specific viral infections and the potential need for dose adjustment based on patient health.

Q: How quickly does Aciherpin start working?

A: Regulatory documents indicate that the prescribed use often involves starting treatment early after symptom onset. While a specific time-to-relief is not typically stated, this approach supports the drug's mechanism of action in helping to slow the virus's spread.

Q: How long does Aciherpin stay in your system after stopping?

A: Pharmacokinetic data from official sources indicate that the drug has a relatively short plasma elimination half-life of approximately 2.5 to 3.3 hours in individuals with normal kidney function. This means the drug is generally eliminated from the body within a day or two after the last dose, though elimination will take longer if kidney function is impaired.

Q: What is the difference between Aciherpin capsule and Aciherpin tablet?

A: Aciherpin (Acyclovir) is available in multiple oral forms, including capsules and tablets, both containing the same active ingredient. These forms differ primarily in the way they are manufactured and the non-active ingredients they contain, but both are designed for systemic absorption into the body.

Q: Can Aciherpin be crushed or split if it is a tablet?

A: Most standard oral tablets are designed to be swallowed whole. While some specific oral formulations, such as those intended for buccal (gum) application, carry an explicit warning not to crush or chew, official instructions must be consulted regarding the physical modification of any prescribed oral form.

Q: Can I take Aciherpin if I am also taking vitamins or supplements?

A: Regulatory information notes that Aciherpin absorption is not significantly affected by food. Official guidance emphasizes the importance of informing a healthcare professional about all medicines and supplements, including vitamins and herbal products, prior to treatment.

Q: Does Aciherpin interact with pain relievers like ibuprofen?

A: Official regulatory documents explicitly list interactions with certain medications that affect kidney clearance, such as Probenecid and Cimetidine. While common pain relievers like ibuprofen are not explicitly listed in the major interaction tables, official guidance notes caution for concurrent use with any medication known to affect kidney function.

Q: Does Aciherpin affect the effectiveness of birth control pills?

A: Official drug interaction checkers generally report no known interaction between Aciherpin (Acyclovir) and common hormonal contraceptives that would affect the contraceptive's efficacy. However, gastrointestinal side effects such as severe vomiting or diarrhea may affect the absorption of oral contraceptive pills, and this potential should be discussed with a healthcare professional.

Q: Is it possible to be allergic to Aciherpin?

A: Yes. Official regulatory documents list hypersensitivity reactions (allergic reactions) as possible adverse effects. A known history of allergy or hypersensitivity to Acyclovir or its related drug, Valaciclovir, is a formal contraindication (a reason not to use the drug).

Q: Is it normal to feel tired when first starting Aciherpin?

A: Yes, official product information lists feelings of tiredness or fatigue among the documented side effects. This effect is described as generally mild.

Q: Is it common for Aciherpin to cause a rash?

A: Official adverse event data indicates that general skin reactions, such as a rash or hives, are documented side effects of Aciherpin. However, they are typically categorized as uncommon to rare compared to the most frequently reported side effects like headache or nausea.

Q: Does Aciherpin make you sensitive to the sun?

A: Some official patient information sources advise that your skin may become sensitive to sunlight as a possible side effect of Aciherpin. This potential side effect is noted in official patient information.

Q: Is there a link between Aciherpin and mental fog or concentration issues?

A: Official side effect lists include common neurological effects like dizziness and headache. Although mental fog is not explicitly named, more severe neurological events, such as confusion or hallucinations, are listed as rare adverse reactions, particularly in older adults or those with kidney impairment.

Q: Does Aciherpin affect blood pressure readings?

A: Changes in blood pressure are not typically listed among the common adverse effects in official regulatory documents. Regulatory documents list other systemic effects, but changes in blood pressure are not specifically noted as common or expected adverse effects.

Q: What should I do if I notice a change in my heart rate while taking Aciherpin?

A: While not a common side effect, some official sources list symptoms such as a fast heartbeat (palpitations) among the serious adverse events reported. Any concerning changes in heart rate or other severe symptoms should be brought to the attention of a healthcare professional immediately.

Q: Can Aciherpin be used by people with a history of kidney problems?

A: Aciherpin is primarily eliminated through the kidneys, so patients with existing renal impairment (kidney problems) require special caution. Official guidelines mandate that the dosage and frequency must be reduced in this population to prevent the drug from building up in the body and causing side effects.

Q: Is Aciherpin safe for older adults (seniors)?

A: Use in older adults is generally possible, but regulatory documents note that due to age-related changes in kidney function, they are at an increased susceptibility to neurological side effects. Because of this, a reduced dose is often necessary, and close monitoring is often recommended.

Q: Can people with liver conditions use Aciherpin?

A: Official documents note that Aciherpin's metabolism by liver enzymes is minimal, suggesting a low potential for interactions or issues related to the liver's processing of the drug. However, as with any pre-existing condition, the decision to use the drug is based on a professional evaluation of the patient's overall health.

Q: Why does Aciherpin have a warning about certain medical conditions?

A: Warnings exist primarily because the drug is eliminated through the kidneys and can potentially cause neurological side effects, especially if drug levels are too high. Therefore, individuals with existing renal impairment or certain other neurological conditions are noted to require careful dose adjustment and monitoring.

Q: What does 'contraindication' mean regarding Aciherpin use?

A: A contraindication is an official statement that describes a condition or circumstance where the use of Aciherpin is potentially unsafe and should be strictly avoided. For Aciherpin, the main contraindication is a known hypersensitivity or allergy to the drug itself.

Q: Can I use Aciherpin if I have diabetes?

A: Official documents do not list diabetes as a direct contraindication. However, some clinical case reports suggest that patients with diabetes may be at a higher risk of developing kidney-related adverse effects if they also have underlying kidney impairment, making careful monitoring important for this population.

Q: Why are people with specific neurological conditions advised against using Aciherpin?

A: Aciherpin has the potential to cause rare but serious neurological events (like confusion or seizures) when drug levels are too high. Because of this, official documents advise increased caution and dose monitoring for individuals with pre-existing conditions that might increase their susceptibility to nervous system side effects.

Q: What age groups is Aciherpin approved for?

A: Official regulatory documents describe dosing and indications for use in a wide range of age groups, including adults, adolescents, and for certain infections like chickenpox, the drug is also approved for use in children, with dosage based on body weight and infection severity.

Q: What are the concerns about Aciherpin use during pregnancy?

A: Official documentation notes that the use of Aciherpin during pregnancy involves a consideration of whether the potential benefit justifies the potential risk. Information also shows the drug passes into breast milk in small amounts.

How should Aciherpin be stored and disposed of?

How to Store and Dispose of Aciherpin?

The storage and disposal of Aciherpin (Aciclovir) must follow regulatory requirements to maintain product quality and safety.


Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection Do not freeze. Protect from light and moisture.
Packaging Keep in the original container and ensure it is tightly closed.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Aciherpin must not be disposed of in wastewater (e.g., toilet or sink). Disposal must follow local regulations. The product should be taken to an official medicine take-back program. If a take-back program is unavailable, follow the home disposal procedure by mixing the medicine with an undesirable substance before sealing and placing it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aciherpin found in:

A-Z Index: